Prostate cancer epidemiology in a rural area of north Western Greece

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 3, 2012, Pages 999-1002

  Grivas, N ^a   Hastazeris, K ^a   Kafarakis, V ^a   Tsimaris, I ^a   Xousianitis, Z ^a   Makatsori, A ^a   Raptis, P ^a   Aspiotis, S ^a   Ioachim, E ^a   Ntemou, A ^a   Kitsiou, E ^a   Malamou Mitsi, V ^b   Sofikitis, N ^b   Kordela, V ^c   Papandreou, C ^d   Agnantis, N J ^b   Stavropoulos, N E ^a  

^a Hatzikosta General Hospital of Ioannina   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c General Hospital of Preveza   (Greece)

^d Department of Urology   (Greece)

Author keywords

Greece; Incidence; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; CANCER GRADING; GREECE; HEALTH; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; GREECE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RURAL HEALTH;

EID: 84871686103     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.3.999     Document Type: Article

References (13)

1. Boyle P, Severi G, Giles GG (2003). The epidemiology of prostate cancer. Urol Clin North Am, 30, 209-17.
2. Bioteach. Assessed 14 December 2005 www.bioteach.ubc.ca/Biomedicine/ProstateCancer/
3. CA: A Cancer Journal for Clinicians 61:Issue 2, MARCH/APRIL 2011. Article first published online: 4 FEB 2011. Available online at http://cajournal.org and http://cacancerjournal.org.
4. Chou Roger, Croswel M Jennifer, Dana Tracy, et al (2011). screening for prostate cancer: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med, 155,762-71.
5. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].IARC, Lyon.
6. Higginbotham JC, Moulder J, Currier M (2001). Rural v. urban aspects of cancer: first-year data from the Mississippi Central Cancer Registry. Fam Community Health, 24, 1-9.
7. Larranaga N, Galceran J, Ardanaz E, et al (2010). Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality. Ann Oncol, 21, 83-9
8. McLafferty S, Wang F (2009). Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois. Cancer, 115, 2755-64.
9. Merrill RM, Feuer EJ, Warren JL et al (1999). Role of transurethral resection of the prostate in population-based prostate cancer incidence rates. Am J Epidemiol, 150, 848-60.
10. Muir CS, Nectoux J, Staszewski J (1991). The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol, 30, 133-40.
11. Potosky AL, Kessler L, Gridley G, et al (1990). Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst, 82, 1624-8.
12. Potosky AL, Miller BA, Albertsen PC et al (1995). The role of increasing detection in the rising incidence of prostate cancer. JAMA, 273, 548-52.
13. Yavuz SS, Dilek S, Aye TS, et al (2008). Dietary agents in prevention of prostate cancer. Asian Pac J Cancer Prev, 9, 183-6